rs17661203

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000037.4(ANK1):​c.909+7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.053 in 1,613,864 control chromosomes in the GnomAD database, including 2,633 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.042 ( 169 hom., cov: 32)
Exomes 𝑓: 0.054 ( 2464 hom. )

Consequence

ANK1
NM_000037.4 splice_region, intron

Scores

2
Splicing: ADA: 0.00008749
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.270

Publications

4 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 8-41723118-T-C is Benign according to our data. Variant chr8-41723118-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 261322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.054 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000037.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_000037.4
MANE Select
c.909+7A>G
splice_region intron
N/ANP_000028.3
ANK1
NM_001142446.2
c.1008+7A>G
splice_region intron
N/ANP_001135918.1
ANK1
NM_020476.3
c.909+7A>G
splice_region intron
N/ANP_065209.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000289734.13
TSL:1 MANE Select
c.909+7A>G
splice_region intron
N/AENSP00000289734.8
ANK1
ENST00000265709.14
TSL:1
c.1008+7A>G
splice_region intron
N/AENSP00000265709.8
ANK1
ENST00000347528.8
TSL:1
c.909+7A>G
splice_region intron
N/AENSP00000339620.4

Frequencies

GnomAD3 genomes
AF:
0.0416
AC:
6329
AN:
152150
Hom.:
167
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0205
Gnomad AMI
AF:
0.0603
Gnomad AMR
AF:
0.0401
Gnomad ASJ
AF:
0.0265
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.00973
Gnomad FIN
AF:
0.0767
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0555
Gnomad OTH
AF:
0.0325
GnomAD2 exomes
AF:
0.0460
AC:
11570
AN:
251472
AF XY:
0.0432
show subpopulations
Gnomad AFR exome
AF:
0.0198
Gnomad AMR exome
AF:
0.0700
Gnomad ASJ exome
AF:
0.0258
Gnomad EAS exome
AF:
0.00120
Gnomad FIN exome
AF:
0.0764
Gnomad NFE exome
AF:
0.0544
Gnomad OTH exome
AF:
0.0436
GnomAD4 exome
AF:
0.0541
AC:
79127
AN:
1461596
Hom.:
2464
Cov.:
32
AF XY:
0.0523
AC XY:
38011
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.0210
AC:
702
AN:
33476
American (AMR)
AF:
0.0672
AC:
3006
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0264
AC:
691
AN:
26132
East Asian (EAS)
AF:
0.00118
AC:
47
AN:
39700
South Asian (SAS)
AF:
0.0150
AC:
1292
AN:
86254
European-Finnish (FIN)
AF:
0.0719
AC:
3843
AN:
53418
Middle Eastern (MID)
AF:
0.0127
AC:
73
AN:
5768
European-Non Finnish (NFE)
AF:
0.0599
AC:
66642
AN:
1111734
Other (OTH)
AF:
0.0469
AC:
2831
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
3777
7553
11330
15106
18883
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2548
5096
7644
10192
12740
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0416
AC:
6336
AN:
152268
Hom.:
169
Cov.:
32
AF XY:
0.0409
AC XY:
3043
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.0205
AC:
852
AN:
41554
American (AMR)
AF:
0.0401
AC:
613
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0265
AC:
92
AN:
3466
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5176
South Asian (SAS)
AF:
0.00974
AC:
47
AN:
4824
European-Finnish (FIN)
AF:
0.0767
AC:
814
AN:
10616
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0555
AC:
3776
AN:
68016
Other (OTH)
AF:
0.0354
AC:
75
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
315
630
945
1260
1575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
80
160
240
320
400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0477
Hom.:
168
Bravo
AF:
0.0390
Asia WGS
AF:
0.0180
AC:
65
AN:
3478
EpiCase
AF:
0.0466
EpiControl
AF:
0.0519

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Hereditary spherocytosis type 1 (4)
-
-
3
not provided (3)
-
-
1
not specified (1)
-
-
1
Spherocytosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
5.1
DANN
Benign
0.44
PhyloP100
0.27
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000087
dbscSNV1_RF
Benign
0.0
Splicevardb
2.0
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17661203; hg19: chr8-41580636; API